Millennium Management LLC Increases Stake in Sensei Biotherapeutics to 9.6%

On May 15, 2026, Millennium Management LLC and its affiliated reporting persons, including Israel A. Englander, filed a Schedule 13G regarding their holdings in Sensei Biotherapeutics, Inc. (SNSE). The filing reveals that as of February 24, 2026, the reporting persons beneficially owned 84,541 shares, representing 6.7% of the company. Their ownership subsequently increased, surpassing the 10% threshold on March 26, 2026, with 127,095 shares. As of the most recent reporting date of May 14, 2026, the group held an aggregate of 128,761 shares of common stock, which represents approximately 9.6% of the outstanding shares based on 1,341,140 shares outstanding as of April 13, 2026. The reporting persons include ICS Opportunities II LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. The filing indicates that the shares were acquired for investment purposes and not with the intent to change or influence control of the issuer. All shares are reported as having shared voting and dispositive power among the reporting group.